G Iiekking Doug's most recent trade in Usana Health Sciences Inc was a trade of 29,877 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 27, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 29,877 | 51,426 | - | - | Restricted Stock Units | |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 4,085 | 21,549 | - | - | Restricted Stock Units | |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 4,085 | 7,300 (0%) | 0% | - | Common Stock | |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.65 per share. | 08 Feb 2025 | 2,752 | 4,548 (0%) | 0% | 30.7 | 84,349 | Common Stock |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 2,322 | 4,779 (0%) | 0% | - | Common Stock | |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 2,322 | 25,634 | - | - | Restricted Stock Units | |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.65 per share. | 08 Feb 2025 | 1,564 | 3,215 (0%) | 0% | 30.7 | 47,937 | Common Stock |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 3,533 | 3,533 (0%) | 0% | - | Common Stock | |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 3,533 | 30,188 | - | - | Restricted Stock Units | |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 2,232 | 27,956 | - | - | Restricted Stock Units | |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 2,232 | 3,738 (0%) | 0% | - | Common Stock | |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.21 per share. | 06 Feb 2025 | 2,027 | 1,506 (0%) | 0% | 31.2 | 63,263 | Common Stock |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.65 per share. | 06 Feb 2025 | 1,281 | 2,457 (0%) | 0% | 30.7 | 39,263 | Common Stock |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 44.76 per share. | 07 May 2024 | 5,198 | 0 (0%) | 0% | 44.8 | 232,677 | Common Stock |
Usana Health Sciences Inc
|
Doug G Iiekking | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 16,338 | 33,721 | - | - | Restricted Stock Units | |
Usana Health Sciences Inc
|
Doug Iiekking G | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 2,321 | 6,530 (0%) | 0% | - | Common Stock | |
Usana Health Sciences Inc
|
Iiekking Doug G | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 2,321 | 17,383 | - | - | Restricted Stock Units | |
Usana Health Sciences Inc
|
Doug Iiekking G | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.85 per share. | 08 Feb 2024 | 1,332 | 5,198 (0%) | 0% | 50.8 | 67,732 | Common Stock |
Usana Health Sciences Inc
|
G Doug Iiekking | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 3,533 | 21,935 | - | - | Restricted Stock Units | |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 3,533 | 5,285 (0%) | 0% | - | Common Stock | |
Usana Health Sciences Inc
|
Doug G Iiekking | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 2,231 | 19,704 | - | - | Restricted Stock Units | |
Usana Health Sciences Inc
|
G Iiekking Doug | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 2,231 | 5,489 (0%) | 0% | - | Common Stock | |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.80 per share. | 06 Feb 2024 | 2,027 | 3,258 (0%) | 0% | 47.8 | 96,891 | Common Stock |
Usana Health Sciences Inc
|
G Doug Iiekking | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.71 per share. | 06 Feb 2024 | 1,280 | 4,209 (0%) | 0% | 49.7 | 63,629 | Common Stock |
Usana Health Sciences Inc
|
G Iiekking Doug | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2024 | 3,047 | 3,047 (0%) | 0% | - | Common Stock | |
Usana Health Sciences Inc
|
G Doug Iiekking | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2024 | 3,047 | 25,468 | - | - | Restricted Stock Units | |
Usana Health Sciences Inc
|
Iiekking Doug G | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.23 per share. | 03 Feb 2024 | 1,295 | 1,752 (0%) | 0% | 47.2 | 61,163 | Common Stock |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 61.71 per share. | 15 Feb 2023 | 5,338 | 0 (0%) | 0% | 61.7 | 329,384 | Common Stock |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 14,131 | 33,069 | - | - | Restricted Stock Units | |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 2,322 | 6,275 (0%) | 0% | - | Common Stock | |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 2,322 | 28,515 | - | - | Restricted Stock Units | |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 2,232 | 4,854 (0%) | 0% | - | Common Stock | |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 2,232 | 30,837 | - | - | Restricted Stock Units | |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.35 per share. | 06 Feb 2023 | 937 | 5,338 (0%) | 0% | 61.4 | 57,485 | Common Stock |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.76 per share. | 06 Feb 2023 | 901 | 3,953 (0%) | 0% | 59.8 | 53,844 | Common Stock |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 3,047 | 3,047 (0%) | 0% | - | Common Stock | |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 3,047 | 20,305 | - | - | Restricted Stock Units | |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 1,367 | 18,938 | - | - | Restricted Stock Units | |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 1,367 | 3,174 (0%) | 0% | - | Common Stock | |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.04 per share. | 03 Feb 2023 | 1,240 | 1,807 (0%) | 0% | 60.0 | 74,450 | Common Stock |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.04 per share. | 03 Feb 2023 | 552 | 2,622 (0%) | 0% | 60.0 | 33,142 | Common Stock |
Usana Health Sciences Inc
|
Iiekking G Doug | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 70.51 per share. | 01 Aug 2022 | 2,924 | 0 (0%) | 0% | 70.5 | 206,159 | Common Stock |
Usana Health Sciences Inc
|
Iiekking G Doug | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 8,926 | 25,674 | - | - | Restricted Stock Units | |
Usana Health Sciences Inc
|
Iiekking G Doug | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 2,322 | 5,819 (0%) | 0% | - | Common Stock | |
Usana Health Sciences Inc
|
Iiekking G Doug | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 2,322 | 23,352 | - | - | Restricted Stock Units | |
Usana Health Sciences Inc
|
Iiekking G Doug | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.30 per share. | 07 Feb 2022 | 1,495 | 4,324 (0%) | 0% | 94.3 | 140,979 | Common Stock |
Usana Health Sciences Inc
|
Iiekking G Doug | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 3,048 | 19,587 | - | - | Restricted Stock Units | |
Usana Health Sciences Inc
|
Iiekking G Doug | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 3,048 | 4,448 (0%) | 0% | - | Common Stock | |
Usana Health Sciences Inc
|
Iiekking G Doug | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.82 per share. | 03 Feb 2022 | 1,962 | 2,486 (0%) | 0% | 93.8 | 184,075 | Common Stock |
Usana Health Sciences Inc
|
Iiekking G Doug | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 1,473 | 4,445 (0%) | 0% | - | Common Stock |